Resolution Bioscience logo — Leading developer of NGS technologies, including in cfDNA li...

Resolution Bioscience

Leading developer of NGS technologies, including in cfDNA liquid biopsies for cancer diagnostic. Part of Exact Sciences.

Founded 2012 United States Kirkland, United States 24 employees Biotechnology, Health Care

General Information

Company Name Resolution Bioscience
Founded Year 2012
Location United States Kirkland, United States +1
Employees 24
Industries Biotechnology, Health Care
Social

Get notified when Resolution Bioscience moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Resolution Bioscience

Resolution Bioscience is a prominent player in the field of Next Generation Sequencing (NGS) technologies, particularly in the development of cfDNA liquid biopsies for cancer diagnostics. As part of Exact Sciences, the company is at the forefront of pioneering innovative cancer diagnostic solutions that empower physicians to customize treatments for each patient using a simple blood test – a liquid biopsy. Their proprietary molecular analytics platform has the capability to extract actionable information from cell-free DNA, a feat previously only achievable through invasive biopsy procedures. With the development of more than 50 focused panels, Resolution Bioscience has demonstrated a dedicated focus on progress and is currently engaged in the creation of companion diagnostics to support therapeutic approvals. This commitment underscores the company's dedication to enhancing cancer outcomes through a comprehensive suite of clinical tests aimed at guiding the selection of targeted therapies and monitoring their efficacy over time. Founded in 2012, Resolution Bioscience operates within the Biotechnology and Health Care industries, showcasing its commitment to advancing medical technologies for the betterment of healthcare. Despite the absence of specific headquarter information and details regarding last investment and last investment investors, Resolution Bioscience's innovative approach and collaboration with Exact Sciences position it as a promising entity in the realm of cancer diagnostics and precision medicine.

Taxonomy: NGS Technology, Molecular Biology, Cancer Diagnostics, cfDNA, circulating biomarkers, IVD, CDx, Next Generation Sequencing, Genetics, liquid biopsy, Liquid Biopsy, ctDNA

No funding data available for Resolution Bioscience yet.

Get notified when Resolution Bioscience raises funding

Resolution Bioscience Alternatives & Competitors

Resolution Bioscience vs

Founded in November, 2014, Genecast (Beijing) Biotechnology Co. is located in HealthWork (Beijing) I...

Series E
21 employees
Biotechnology, Health Care
Resolution Bioscience vs

Leading the way in patient-specific cancer genome analysis with groundbreaking technologies for non-...

Series C
0-1 employees
Analytics, Biotechnology
Resolution Bioscience vs
Amadix
Amadix Spain

Early cancer detection in blood

Grant
43 employees
Biopharma, Biotechnology

FAQ About Resolution Bioscience

Leading developer of NGS technologies, including in cfDNA liquid biopsies for cancer diagnostic. Part of Exact Sciences.
Resolution Bioscience was founded in 2012.
Resolution Bioscience is headquartered in Kirkland, United States.
Resolution Bioscience operates in the following industries: Biotechnology, Health Care.
Resolution Bioscience has approximately 24 employees.
Top alternatives and competitors to Resolution Bioscience include GeneCast Biotechnology Co., Ltd., Personal Genome Diagnostics, Amadix, PetDx, Anchor Molecular. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Resolution Bioscience and GeneCast Biotechnology Co., Ltd. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Resolution Bioscience and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy